share_log

CytoMed Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Loh Yuin Han

SEC announcement ·  Apr 17, 2023 06:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more